EPHX2 and cardiomyopathy: The study provides evidence that diabetes initiates cardiomyopathy by increasing sEH, reducing cytochrome P450 2J, and decreasing cardioprotective EETs, finally attenuating cardiotoxicity mediated by the reduction of high glucose in cardiac cells (Alaeddine et al., 2021).